Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 28;9(8):949.
doi: 10.3390/healthcare9080949.

Repetitive Transcranial Magnetic Stimulation in the Treatment of Alzheimer's Disease and Other Dementias

Affiliations
Review

Repetitive Transcranial Magnetic Stimulation in the Treatment of Alzheimer's Disease and Other Dementias

Athina-Maria Aloizou et al. Healthcare (Basel). .

Abstract

Dementia is a debilitating impairment of cognitive functions that affects millions of people worldwide. There are several diseases belonging to the dementia spectrum, most prominently Alzheimer's disease (AD), vascular dementia (VD), Lewy body dementia (LBD) and frontotemporal dementia (FTD). Repetitive transcranial magnetic stimulation (rTMS) is a safe, non-invasive form of brain stimulation that utilizes a magnetic coil to generate an electrical field and induce numerous changes in the brain. It is considered efficacious for the treatment of various neuropsychiatric disorders. In this paper, we review the available studies involving rTMS in the treatment of these dementia types. The majority of studies have involved AD and shown beneficial effects, either as a standalone, or as an add-on to standard-of-care pharmacological treatment and cognitive training. The dorsolateral prefrontal cortex seems to hold a central position in the applied protocols, but several parameters still need to be defined. In addition, rTMS has shown potential in mild cognitive impairment as well. Regarding the remaining dementias, research is still at preliminary phases, and large, randomized studies are currently lacking.

Keywords: Alzheimer’s disease; dementia; magnetic stimulation; non-pharmacological treatments; rTMS.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of Alzheimer’s disease pathology. The figure was prepared using a BioRender template under license (to DPB).

References

    1. Takizawa C., Thompson P.L., van Walsem A., Faure C., Maier W.C. Epidemiological and Economic Burden of Alzheimer’s Disease: A Systematic Literature Review of Data across Europe and the United States of America. J. Alzheimer’s Dis. 2015;43:1271–1284. doi: 10.3233/JAD-141134. - DOI - PubMed
    1. Hsu W.-Y., Ku Y., Zanto T.P., Gazzaley A. Effects of Noninvasive Brain Stimulation on Cognitive Function in Healthy Aging and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Neurobiol. Aging. 2015;36:2348–2359. doi: 10.1016/j.neurobiolaging.2015.04.016. - DOI - PMC - PubMed
    1. Barker A.T., Jalinous R., Freeston I.L. Non-Invasive Magnetic Stimulation of Human Motor Cortex. Lancet. 1985;1:1106–1107. doi: 10.1016/S0140-6736(85)92413-4. - DOI - PubMed
    1. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety of TMS Consensus Group Safety, Ethical Considerations, and Application Guidelines for the Use of Transcranial Magnetic Stimulation in Clinical Practice and Research. Clin.Neurophysiol. 2009;120:2008–2039. doi: 10.1016/j.clinph.2009.08.016. - DOI - PMC - PubMed
    1. Aloizou A., Pateraki G., Anargyros K., Siokas V., Bakirtzis C., Liampas I., Nousia A., Nasios G., Sgantzos M., Peristeri E., et al. Transcranial Magnetic Stimulation (TMS) and Repetitive TMS in Multiple Sclerosis. Rev. Neurosci. 2021 doi: 10.1515/revneuro-2020-0140. - DOI - PubMed